​

Cardinal Health (CAH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CAH Stock Forecast

Cardinal Health (CAH) stock forecast, based on 30 Wall Street analysts, predicts a 12-month average price target of $148.00, with a high of $148.00 and a low of $148.00. This represents a 9.87% increase from the last price of $134.71.

$95 $106 $117 $128 $139 $150 High: $148 Avg: $148 Low: $148 Last Closed Price: $134.71

CAH Stock Rating

Cardinal Health stock's rating consensus is Buy, based on 30 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (50.00%), 15 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 30 0 15 15 Strong Sell Sell Hold Buy Strong Buy

CAH Price Target Upside V Benchmarks

TypeNameUpside
StockCardinal Health9.87%
SectorHealthcare Stocks 35.25%
IndustryMedical Distribution Stocks6.26%

Price Target Trends

1M3M12M
# Anlaysts-113
Avg Price Target-$148.00$122.85
Last Closing Price$134.71$134.71$134.71
Upside/Downside-9.87%-8.80%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25295-117
Mar, 25296--17
Feb, 25286-117
Jan, 25289-120
Dec, 2425101119
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 04, 2025Kristina RuggeriArgus Research$148.00$125.1718.24%9.87%
Sep 23, 2024Eric ColdwellRobert W. Baird$140.00$112.3024.67%3.93%
Sep 11, 2024David ToungArgus Research$125.00$112.3611.25%-7.21%
Aug 16, 2024George HillDeutsche Bank$119.00$107.9110.28%-11.66%
Aug 15, 2024Elizabeth AndersonEvercore ISI$115.00$107.716.77%-14.63%
Aug 15, 2024Erin WrightMorgan Stanley$119.00$106.3611.88%-11.66%
Aug 15, 2024Ann HynesMizuho Securities$110.00$107.392.43%-18.34%
Aug 15, 2024Eric ColdwellRobert W. Baird$137.00$107.3327.64%1.70%
Aug 15, 2024Stephen BaxterWells Fargo$101.00$106.36-5.04%-25.02%
Jun 11, 2024Garrett NelsonCFRA$111.00$99.0112.11%-17.60%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 31, 2025Cowen & Co.BuyBuyhold
Jan 10, 2025CitigroupNeutralNeutralhold
Jan 07, 2025Evercore ISIOutperformOutperformupgrade
Sep 23, 2024Cowen & Co.HoldHoldhold
Aug 16, 2024Deutsche BankHoldHoldhold
Aug 15, 2024Cowen & Co.HoldHoldhold
Aug 15, 2024Evercore ISIOutperformOutperformhold
Aug 15, 2024Cowen & Co.BuyBuyhold
Aug 15, 2024Morgan StanleyOverweightOverweighthold
Aug 14, 2024Wells FargoUnderweightUnderweighthold

Financial Forecast

EPS Forecast

$-15 $-9 $-3 $3 $9 $15 Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-12.60$2.09$-3.34$1.00------
Avg Forecast$5.30$5.99$5.19$5.74$7.36$7.87$8.76$9.68$10.78$12.76
High Forecast$5.48$6.19$5.36$5.87$7.37$7.92$8.95$10.83$11.02$13.05
Low Forecast$5.18$5.86$5.07$5.63$7.34$7.78$8.45$7.95$10.56$12.50
Surprise %-337.74%-65.11%-164.35%-82.58%------

Revenue Forecast

$150B $190B $230B $270B $310B $350B Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$152.92B$162.47B$181.36B$205.01B------
Avg Forecast$153.20B$160.21B$178.77B$204.30B$225.71B$221.21B$239.25B$256.89B$275.37B$322.52B
High Forecast$157.13B$164.32B$183.35B$207.84B$226.11B$223.15B$241.57B$257.33B$280.14B$328.11B
Low Forecast$150.51B$157.40B$175.63B$201.12B$225.39B$219.46B$236.65B$256.45B$271.08B$317.50B
Surprise %-0.18%1.41%1.45%0.35%------

Net Income Forecast

$-5B $-3B $-2B $100M $2B $4B Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-3.69B$611.00M$-932.00M$261.00M------
Avg Forecast$-3.58B$1.20B$601.41M$1.42B$1.28B$1.94B$2.15B$2.32B$2.66B$3.15B
High Forecast$-2.63B$1.51B$721.69M$1.45B$1.83B$1.96B$2.21B$2.67B$2.72B$3.22B
Low Forecast$-4.53B$896.01M$481.12M$1.39B$734.28M$1.92B$2.09B$1.96B$2.61B$3.09B
Surprise %3.27%-49.25%-254.97%-81.60%------

CAH Forecast FAQ

Is Cardinal Health stock a buy?

Cardinal Health stock has a consensus rating of Buy, based on 30 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 15 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cardinal Health is a favorable investment for most analysts.

What is Cardinal Health's price target?

Cardinal Health's price target, set by 30 Wall Street analysts, averages $148 over the next 12 months. The price target range spans from $148 at the low end to $148 at the high end, suggesting a potential 9.87% change from the previous closing price of $134.71.

How does Cardinal Health stock forecast compare to its benchmarks?

Cardinal Health's stock forecast shows a 9.87% upside, underperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical distribution stocks industry (6.26%).

What is the breakdown of analyst ratings for Cardinal Health over the past three months?

  • April 2025: 11.76% Strong Buy, 52.94% Buy, 29.41% Hold, 0% Sell, 5.88% Strong Sell.
  • March 2025: 11.76% Strong Buy, 52.94% Buy, 35.29% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 11.76% Strong Buy, 47.06% Buy, 35.29% Hold, 0% Sell, 5.88% Strong Sell.

What is Cardinal Health’s EPS forecast?

Cardinal Health's average annual EPS forecast for its fiscal year ending in June 2024 is $7.36, marking a 636.00% increase from the reported $1 in 2023. Estimates for the following years are $7.87 in 2025, $8.76 in 2026, $9.68 in 2027, $10.78 in 2028, and $12.76 in 2029.

What is Cardinal Health’s revenue forecast?

Cardinal Health's average annual revenue forecast for its fiscal year ending in June 2024 is $225.71B, reflecting a 10.10% increase from the reported $205.01B in 2023. The forecast for 2025 is $221.21B, followed by $239.25B for 2026, $256.89B for 2027, $275.37B for 2028, and $322.52B for 2029.

What is Cardinal Health’s net income forecast?

Cardinal Health's net income forecast for the fiscal year ending in June 2024 stands at $1.28B, representing an 390.42% increase from the reported $261M in 2023. Projections indicate $1.94B in 2025, $2.15B in 2026, $2.32B in 2027, $2.66B in 2028, and $3.15B in 2029.